(Q30934414)

English

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

M Laakso

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Markolf Hanefeld

4

object named as

M Hanefeld

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

J-L Chiasson

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

R G Josse

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

R Gomis

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

A Karasik

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

STOP-NIDDM Trial Research Group

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

969-75; discussion 976-7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice Guidelines For Primary Care Physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of weight loss on regional fat distribution and insulin sensitivity in obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scope and specificity of acarbose in slowing carbohydrate absorption in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of training on insulin-mediated glucose uptake in human muscle

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus. The Finnish Acargbos Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-challenge hyperglycaemia is associated with premature death and macrovascular complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15164169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-004-1409-4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30934414&oldid=2195041782"